Literature DB >> 10577906

Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.

M Floeth1, L Bruckner-Tuderman.   

Abstract

Junctional epidermolysis bullosa (JEB), a genetically heterogeneous group of blistering skin diseases, can be caused by mutations in the genes encoding laminin 5 or collagen XVII, which are components of the hemidesmosome-anchoring filament complex in the skin. Here, a family with severe nonlethal JEB and with mutations in genes for both proteins was identified. The index patient was compound heterozygous for the COL17A1 mutations L855X and R1226X and was heterozygous for the LAMB3 mutation R635X. As a consequence, two functionally related proteins were affected. Absence of collagen XVII and attenuated laminin 5 expression resulted in rudimentary hemidesmosome structure and separation of the epidermis from the basement membrane, with severe skin blistering as the clinical manifestation. In contrast, single heterozygotes carrying either (1) one or the other of the COL17A1 null alleles or (2) a double heterozygote for a COL17A1 and a LAMB3 null allele did not have a pathological skin phenotype. These observations indicate that the known allelic heterogeneity in JEB is further complicated by interactions between unlinked mutations. They also demonstrate that identification of one mutation in one gene is not sufficient for determination of the genetic basis of JEB in a given family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577906      PMCID: PMC1288363          DOI: 10.1086/302672

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  33 in total

1.  IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa.

Authors:  J E Kuster; M H Guarnieri; J G Ault; L Flaherty; P J Swiatek
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

2.  A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.

Authors:  S Chavanas; Y Gache; G Tadini; L Pulkkinen; J Uitto; J P Ortonne; G Meneguzzi
Journal:  J Invest Dermatol       Date:  1997-07       Impact factor: 8.551

3.  Dominant and digenic mutations in the peripherin/RDS and ROM1 genes in retinitis pigmentosa.

Authors:  T P Dryja; L B Hahn; K Kajiwara; E L Berson
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-09       Impact factor: 4.799

4.  Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy.

Authors:  L Pulkkinen; G Meneguzzi; J A McGrath; Y Xu; C Blanchet-Bardon; J P Ortonne; A M Christiano; J Uitto
Journal:  J Invest Dermatol       Date:  1997-08       Impact factor: 8.551

5.  Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA).

Authors:  R Morell; R A Spritz; L Ho; J Pierpont; W Guo; T B Friedman; J H Asher
Journal:  Hum Mol Genet       Date:  1997-05       Impact factor: 6.150

6.  Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa.

Authors:  H Schumann; N Hammami-Hauasli; L Pulkkinen; A Mauviel; W Küster; U Lüthi; K Owaribe; J Uitto; L Bruckner-Tuderman
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

7.  Immunofluorescence mapping of antigenic determinants within the dermal-epidermal junction in the mechanobullous diseases.

Authors:  H Hintner; G Stingl; G Schuler; P Fritsch; J Stanley; S Katz; K Wolff
Journal:  J Invest Dermatol       Date:  1981-02       Impact factor: 8.551

8.  Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci.

Authors:  K Kajiwara; E L Berson; T P Dryja
Journal:  Science       Date:  1994-06-10       Impact factor: 47.728

9.  The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane.

Authors:  T Masunaga; H Shimizu; C Yee; L Borradori; Z Lazarova; T Nishikawa; K B Yancey
Journal:  J Invest Dermatol       Date:  1997-08       Impact factor: 8.551

10.  Laminin 5 binds the NC-1 domain of type VII collagen.

Authors:  P Rousselle; D R Keene; F Ruggiero; M F Champliaud; M Rest; R E Burgeson
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more
  21 in total

Review 1.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

2.  Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants.

Authors:  R Varki; S Sadowski; E Pfendner; J Uitto
Journal:  J Med Genet       Date:  2006-02-10       Impact factor: 6.318

Review 3.  Back to basics--how the evolution of the extracellular matrix underpinned vertebrate evolution.

Authors:  Julie Huxley-Jones; John W Pinney; John Archer; David L Robertson; Raymond P Boot-Handford
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

4.  Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease.

Authors:  Y Pei; A D Paterson; K R Wang; N He; D Hefferton; T Watnick; G G Germino; P Parfrey; S Somlo; P St George-Hyslop
Journal:  Am J Hum Genet       Date:  2001-01-10       Impact factor: 11.025

Review 5.  Laminin 332 in junctional epidermolysis bullosa.

Authors:  Dimitra Kiritsi; Cristina Has; Leena Bruckner-Tuderman
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

6.  Understanding mutational effects in digenic diseases.

Authors:  Andrea Gazzo; Daniele Raimondi; Dorien Daneels; Yves Moreau; Guillaume Smits; Sonia Van Dooren; Tom Lenaerts
Journal:  Nucleic Acids Res       Date:  2017-09-06       Impact factor: 16.971

7.  The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.

Authors:  Samuel D Quaynor; Hyung-Goo Kim; Elizabeth M Cappello; Tiera Williams; Lynn P Chorich; David P Bick; Richard J Sherins; Lawrence C Layman
Journal:  Fertil Steril       Date:  2011-10-28       Impact factor: 7.329

8.  Sequencing EVC and EVC2 identifies mutations in two-thirds of Ellis-van Creveld syndrome patients.

Authors:  Stuart W J Tompson; Victor L Ruiz-Perez; Helen J Blair; Stephanie Barton; Victoria Navarro; Joanne L Robson; Michael J Wright; Judith A Goodship
Journal:  Hum Genet       Date:  2006-09-21       Impact factor: 4.132

Review 9.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

10.  The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.

Authors:  H Schumann; J Baetge; K Tasanen; F Wojnarowska; H Schäcke; D Zillikens; L Bruckner-Tuderman
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.